Economic productivity loss due to breast cancer in Norway – a case control study using the human capital approach
Nordic Journal of Health Economics
View Archive InfoField | Value | |
Title |
Economic productivity loss due to breast cancer in Norway – a case control study using the human capital approach
|
|
Creator |
Dahl, Fredrik A; HØKH, Research Centre, Akerhus university hospital
Šaltytė Benth, Jūratė; Institute of Clinical Medicine, Campus Ahus, University of Oslo Aas, Eline; Department of Health Management and Health Economics, University of Oslo Lurås, Hilde; HØKH, Research Centre, Akerhus university hospital |
|
Subject |
Health; economics
breast cancer, productivity loss, human capital approach I18 |
|
Description |
We estimate the productivity loss attributable to breast cancer in Norway, using a human capital approach where the value to the national economy of subjects’ labor is estimated through their income. Since the approach takes the viewpoint of the society, it includes reduced labor due to mortality as well as reduction among survivors. A case-control design was used. The Norwegian Cancer Registry identified 2,010 patients aged 45-54 years, with breast cancer as their first life-long malignancy diagnosis in 1992-1996. Statistics Norway matched these with random controls of the same age, marital status and municipality residency, and provided data on pension qualifying income until the year 2005, inflation adjusted to 2012 €. The effect of the cancer diagnosis on income throughout the follow-up period was estimated as the difference between the cases’ and controls’ income, corrected for systematic differences between cases and controls before the diagnosis. A quadratic curve approximation was used to estimate effects after the 13 years follow-up period, and a bootstrap resampling approach was applied to compute confidence intervals (CI). Regression modeling was used to estimate life-long productivity loss as a function of age at diagnosis. This was combined with the current Norwegian age distribution of breast cancer incidence, to estimate the national productivity loss due to breast cancer. For our cohort, the 13-years productivity loss attributable to the diagnosis was estimated to 102,600 € per case, with 95% CI (88,500, 116,700). The life-long estimate was 119,200 €, CI (95,400, 155,600). The annual national productivity loss was estimated to 179,900,000 €, or 58,200 € per case. For those aged < 65 at diagnosis, the estimate was 94,300 € per case. The estimated life-long productivity loss depends heavily on the age at diagnosis. The results can be used for evaluating the societal economic benefit from breast cancer prevention programs. Published: Online December 2017. In print December 2017.
|
|
Publisher |
University of Oslo
|
|
Contributor |
—
|
|
Date |
2017-12-16
|
|
Type |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion Peer-reviewed Article |
|
Format |
application/pdf
|
|
Identifier |
https://www.journals.uio.no/index.php/NJHE/article/view/2981
10.5617/njhe.2981 |
|
Source |
Nordic Journal of Health Economics; Vol 5, No 2 (2017): Nordic Journal of Health Economics; pp. 70-83
1892-9710 1892-9729 |
|
Language |
eng
|
|
Relation |
https://www.journals.uio.no/index.php/NJHE/article/view/2981/5017
|
|
Rights |
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
|
|